RootsAnalysis is pleased to announce the publication of its recent study, titled, “Large Volume Wearable Injectors Market, 2021-2030: Focus on Bolus, Basal andContinuous Delivery Devices.”
Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely future evolution of these self-injection devicesover the next decade. It features an in-depth analysis, highlighting thecapabilities of various stakeholders engaged in this domain. In addition toother elements, the study includes:
· A detailed review of the overall landscape oflarge volume wearable injectors available for delivery of insulin andnon-insulin drugs, in addition to the under development / available drug devicecombinations
· An insightful competitiveness analysis oflarge volume wearable injectors based on various relevant parameters, such assupplier power and product specifications
· Elaborate profiles of the prominent companiesthat develop large volume wearable injectors.
· An analysis of the partnerships that havebeen established in the period between 2015 and 2020.
· A detailed analysis on acquisition targets.
· An in-depth analysis of the various patentsthat have been submitted / filed related to large volume wearable injectorsover the last three decades.
· A list of marketed drugs / therapies andpipeline candidates that are likely to be developed in combination with largevolume wearable injectors in the near future
· A social media analysis depicting prevalentand emerging trends, and the popularityof large volume wearable injectors on Twitter
· A detailed analysis of completed, ongoing andplanned clinical trials
· A case study on the role of contractmanufacturing organizations in the overall manufacturing process / supply chain
· An elaborate discussion on the variousguidelines established by major regulatory bodies for medical device approval,in general.
GetDetailed Report: https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html
Adetailed market forecast, featuring analysis of the financial opportunitywithin the large volume wearable injectors market (for delivery of non-insulinand insulin drugs) across the following segments:
Typeof Device
· Patch Pump / Injectors
· Infusion Pump / Injectors
ProductUsability
· Disposable
· Re-usable
TherapeuticsArea (for non-insulin drugs)
· Neurological Disorders
· Cardiovascular Disorders
· Oncological Disorders
· Infectious Disorders
KeyGeographical Regions
· North America
· Europe
· Asia-Pacific
Keycompanies covered in the report:
· Becton Dickinson
· Bespak (subsidiary of Consort Medical)
· CeQur
· Debiotech
· Eli Lilly
· Enable Injections
· Insulet
· Medtronic
· PharmaSens
· Roche
· SOOIL Development
· Sonceboz
· Sensile Medical (acquired by Gerresheimer)
· SteadyMed Therapeutics (acquired by United Therapeutics)
· Tandem Diabetes Care
· Weibel CDS (acquired by SHL Medical)
· West Pharmaceutical Services
Requestfor PDF Sample:
https://www.rootsanalysis.com/reports/238/request-sample.html
ChapterOutlines
Chapter2 providesan executive summary of the insights captured in our research. It offers ahigh-level view on the current state of the large volume wearable injectorsmarket in the short-mid-term and long term.
Chapter3 providesa general introduction to large volume wearable injectors, highlighting thegrowing demand for medical devices that enable self-administration. The chapterlays emphasis on the need for such devices, in terms of the rising incidenceand prevalence of chronic diseases. Additionally, it provides an overview ofthe different types of self-injection devices available in the market, listingtheir various advantages. It also features a brief discussion on the concernsrelated to the use of such devices.
Chapter4 presentsinformation on the large volume wearable injectors that are capable ofdelivering drugs and drug device combinations designed for delivery of specificdrugs. In addition, the chapter includes a detailed analysis of these injectordevices based on the status of development, type of device (patch pump /injector and infusion pump / injector), type of dose administered (basal, bolusand others), route of administration (subcutaneous and others), mode ofinjection (needle, needle / cannula and needle / catheter), storage capacity ofthe device, actuation mechanism(electromechanical, rotary pump, cell / expanded battery, pressurized gas,osmotic pressure and others), usability (disposable and reusable), availabilityof prefilled drug reservoir and availability of device connectivity. Inaddition, the chapter provides a list of the large volume wearable injectorsfor delivery of insulin, along with the information on the aforementionedparameters and availability of prefilled insulin cartridges, availability ofCGM / BGM systems, availability of Automated Insulin Delivery Feature and typeof remote control features (control within device / PDM / smartphone).
Requestfor Custom Report: https://www.rootsanalysis.com/reports/238/request-customization.html
Also Visit Our Upcoming Reports
BronchialSpasm Market, 2021-2031
PelvicInflammatory Disease Market Size 2021-2031
NoonanSyndrome Market Research Report by 2031
CutaneousLupus Market, 2021-2030
HypothalamicObesity Market by 2030
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in the bio-pharmaceuticalindustry. The in-depth research, analysis and insights are driven by anexperienced leadership team which has gained many years of significantexperience in this sector. If you’d like help with your growing business needs,get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
